AT2A2_HUMAN - dbPTM
AT2A2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID AT2A2_HUMAN
UniProt AC P16615
Protein Name Sarcoplasmic/endoplasmic reticulum calcium ATPase 2
Gene Name ATP2A2
Organism Homo sapiens (Human).
Sequence Length 1042
Subcellular Localization Endoplasmic reticulum membrane
Multi-pass membrane protein . Sarcoplasmic reticulum membrane
Multi-pass membrane protein .
Protein Description This magnesium-dependent enzyme catalyzes the hydrolysis of ATP coupled with the translocation of calcium from the cytosol to the sarcoplasmic reticulum lumen. Isoform 2 is involved in the regulation of the contraction/relaxation cycle. [PubMed: 16402920 Acts as a regulator of TNFSF11-mediated Ca(2+) signaling pathways via its interaction with TMEM64 which is critical for the TNFSF11-induced CREB1 activation and mitochondrial ROS generation necessary for proper osteoclast generation. Association between TMEM64 and SERCA2 in the ER leads to cytosolic Ca (2+) spiking for activation of NFATC1 and production of mitochondrial ROS, thereby triggering Ca (2+) signaling cascades that promote osteoclast differentiation and activation (By similarity]
Protein Sequence MENAHTKTVEEVLGHFGVNESTGLSLEQVKKLKERWGSNELPAEEGKTLLELVIEQFEDLLVRILLLAACISFVLAWFEEGEETITAFVEPFVILLILVANAIVGVWQERNAENAIEALKEYEPEMGKVYRQDRKSVQRIKAKDIVPGDIVEIAVGDKVPADIRLTSIKSTTLRVDQSILTGESVSVIKHTDPVPDPRAVNQDKKNMLFSGTNIAAGKAMGVVVATGVNTEIGKIRDEMVATEQERTPLQQKLDEFGEQLSKVISLICIAVWIINIGHFNDPVHGGSWIRGAIYYFKIAVALAVAAIPEGLPAVITTCLALGTRRMAKKNAIVRSLPSVETLGCTSVICSDKTGTLTTNQMSVCRMFILDRVEGDTCSLNEFTITGSTYAPIGEVHKDDKPVNCHQYDGLVELATICALCNDSALDYNEAKGVYEKVGEATETALTCLVEKMNVFDTELKGLSKIERANACNSVIKQLMKKEFTLEFSRDRKSMSVYCTPNKPSRTSMSKMFVKGAPEGVIDRCTHIRVGSTKVPMTSGVKQKIMSVIREWGSGSDTLRCLALATHDNPLRREEMHLEDSANFIKYETNLTFVGCVGMLDPPRIEVASSVKLCRQAGIRVIMITGDNKGTAVAICRRIGIFGQDEDVTSKAFTGREFDELNPSAQRDACLNARCFARVEPSHKSKIVEFLQSFDEITAMTGDGVNDAPALKKAEIGIAMGSGTAVAKTASEMVLADDNFSTIVAAVEEGRAIYNNMKQFIRYLISSNVGEVVCIFLTAALGFPEALIPVQLLWVNLVTDGLPATALGFNPPDLDIMNKPPRNPKEPLISGWLFFRYLAIGCYVGAATVGAAAWWFIAADGGPRVSFYQLSHFLQCKEDNPDFEGVDCAIFESPYPMTMALSVLVTIEMCNALNSLSENQSLLRMPPWENIWLVGSICLSMSLHFLILYVEPLPLIFQITPLNVTQWLMVLKISLPVILMDETLKFVARNYLEPGKECVQPATKSCSFSACTDGISWPFVLLIMPLVIWVYSTDTNFSDMFWS
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
302-HydroxyisobutyrylationGLSLEQVKKLKERWG
CCCHHHHHHHHHHHC
52.67-
30UbiquitinationGLSLEQVKKLKERWG
CCCHHHHHHHHHHHC
52.6721906983
30 (in isoform 1)Ubiquitination-52.6721890473
30 (in isoform 2)Ubiquitination-52.6721890473
31AcetylationLSLEQVKKLKERWGS
CCHHHHHHHHHHHCC
66.9718530349
31UbiquitinationLSLEQVKKLKERWGS
CCHHHHHHHHHHHCC
66.97-
33AcetylationLEQVKKLKERWGSNE
HHHHHHHHHHHCCCC
54.8618530359
38PhosphorylationKLKERWGSNELPAEE
HHHHHHCCCCCCHHH
21.8521815630
120UbiquitinationENAIEALKEYEPEMG
HHHHHHHHHHCHHHC
66.3621906983
120 (in isoform 1)Ubiquitination-66.3621890473
120 (in isoform 2)Ubiquitination-66.3621890473
122NitrationAIEALKEYEPEMGKV
HHHHHHHHCHHHCCH
34.89-
122PhosphorylationAIEALKEYEPEMGKV
HHHHHHHHCHHHCCH
34.8918083107
1282-HydroxyisobutyrylationEYEPEMGKVYRQDRK
HHCHHHCCHHHCCHH
34.48-
128UbiquitinationEYEPEMGKVYRQDRK
HHCHHHCCHHHCCHH
34.48-
128 (in isoform 1)Ubiquitination-34.4821890473
128 (in isoform 2)Ubiquitination-34.4821890473
130NitrationEPEMGKVYRQDRKSV
CHHHCCHHHCCHHHH
13.17-
135GlycationKVYRQDRKSVQRIKA
CHHHCCHHHHHHHHH
64.37-
141GlycationRKSVQRIKAKDIVPG
HHHHHHHHHHHCCCC
52.12-
1432-HydroxyisobutyrylationSVQRIKAKDIVPGDI
HHHHHHHHHCCCCCE
42.88-
143UbiquitinationSVQRIKAKDIVPGDI
HHHHHHHHHCCCCCE
42.88-
143 (in isoform 2)Ubiquitination-42.88-
1582-HydroxyisobutyrylationVEIAVGDKVPADIRL
EEEECCCCCCCCEEE
44.16-
158UbiquitinationVEIAVGDKVPADIRL
EEEECCCCCCCCEEE
44.16-
158 (in isoform 2)Ubiquitination-44.16-
164MethylationDKVPADIRLTSIKST
CCCCCCEEEEECCCC
32.25115916465
169MalonylationDIRLTSIKSTTLRVD
CEEEEECCCCEEEEE
41.3326320211
169UbiquitinationDIRLTSIKSTTLRVD
CEEEEECCCCEEEEE
41.3321906983
169 (in isoform 1)Ubiquitination-41.3321890473
169 (in isoform 2)Ubiquitination-41.3321890473
170PhosphorylationIRLTSIKSTTLRVDQ
EEEEECCCCEEEEEC
25.5924719451
178UbiquitinationTTLRVDQSILTGESV
CEEEEECHHHCCCCE
18.3321890473
178PhosphorylationTTLRVDQSILTGESV
CEEEEECHHHCCCCE
18.3320068231
181PhosphorylationRVDQSILTGESVSVI
EEECHHHCCCCEEEE
36.9130266825
184PhosphorylationQSILTGESVSVIKHT
CHHHCCCCEEEEECC
22.4930266825
186PhosphorylationILTGESVSVIKHTDP
HHCCCCEEEEECCCC
27.6630266825
1892-HydroxyisobutyrylationGESVSVIKHTDPVPD
CCCEEEEECCCCCCC
37.99-
189AcetylationGESVSVIKHTDPVPD
CCCEEEEECCCCCCC
37.9926051181
189UbiquitinationGESVSVIKHTDPVPD
CCCEEEEECCCCCCC
37.99-
189 (in isoform 2)Ubiquitination-37.99-
191PhosphorylationSVSVIKHTDPVPDPR
CEEEEECCCCCCCCC
36.6822210691
205UbiquitinationRAVNQDKKNMLFSGT
CCCCCCCCCCCCCCC
56.7421890473
205MalonylationRAVNQDKKNMLFSGT
CCCCCCCCCCCCCCC
56.7426320211
205UbiquitinationRAVNQDKKNMLFSGT
CCCCCCCCCCCCCCC
56.7421890473
205 (in isoform 1)Ubiquitination-56.7421890473
205 (in isoform 2)Ubiquitination-56.7421890473
218AcetylationGTNIAAGKAMGVVVA
CCCCCCCCCCEEEEE
30.397364683
226PhosphorylationAMGVVVATGVNTEIG
CCEEEEEECCCCCCH
30.0121406692
230PhosphorylationVVATGVNTEIGKIRD
EEEECCCCCCHHHHH
26.9421406692
239SulfoxidationIGKIRDEMVATEQER
CHHHHHHHHCCHHHC
2.6621406390
242PhosphorylationIRDEMVATEQERTPL
HHHHHHCCHHHCCHH
27.13-
247PhosphorylationVATEQERTPLQQKLD
HCCHHHCCHHHHHHH
27.8323879269
252UbiquitinationERTPLQQKLDEFGEQ
HCCHHHHHHHHHHHH
44.9721906983
252 (in isoform 1)Ubiquitination-44.9721890473
252 (in isoform 2)Ubiquitination-44.9721890473
261PhosphorylationDEFGEQLSKVISLIC
HHHHHHHHHHHHHHH
25.2721406692
268GlutathionylationSKVISLICIAVWIIN
HHHHHHHHHHHHHHH
1.6615489859
294Nitrated tyrosineSWIRGAIYYFKIAVA
CCHHHHHHHHHHHHH
11.43-
294NitrationSWIRGAIYYFKIAVA
CCHHHHHHHHHHHHH
11.4316399855
294NitrationSWIRGAIYYFKIAVA
CCHHHHHHHHHHHHH
11.4316399855
294PhosphorylationSWIRGAIYYFKIAVA
CCHHHHHHHHHHHHH
11.43-
295Nitrated tyrosineWIRGAIYYFKIAVAL
CHHHHHHHHHHHHHH
7.71-
295NitrationWIRGAIYYFKIAVAL
CHHHHHHHHHHHHHH
7.7116399855
295NitrationWIRGAIYYFKIAVAL
CHHHHHHHHHHHHHH
7.7116399855
328UbiquitinationLGTRRMAKKNAIVRS
HCCHHHHHHCHHHHC
36.90-
329UbiquitinationGTRRMAKKNAIVRSL
CCHHHHHHCHHHHCC
41.91-
335PhosphorylationKKNAIVRSLPSVETL
HHCHHHHCCCCCCCC
33.4622210691
338PhosphorylationAIVRSLPSVETLGCT
HHHHCCCCCCCCCCC
37.5726437602
341PhosphorylationRSLPSVETLGCTSVI
HCCCCCCCCCCCEEE
26.7122210691
345PhosphorylationSVETLGCTSVICSDK
CCCCCCCCEEEEECC
24.9928348404
346PhosphorylationVETLGCTSVICSDKT
CCCCCCCEEEEECCC
17.3526437602
350PhosphorylationGCTSVICSDKTGTLT
CCCEEEEECCCCCCC
30.9028348404
352UbiquitinationTSVICSDKTGTLTTN
CEEEEECCCCCCCCC
32.34-
353PhosphorylationSVICSDKTGTLTTNQ
EEEEECCCCCCCCCC
40.1524719451
357PhosphorylationSDKTGTLTTNQMSVC
ECCCCCCCCCCCCHH
24.4424719451
358PhosphorylationDKTGTLTTNQMSVCR
CCCCCCCCCCCCHHE
26.9422210691
361SulfoxidationGTLTTNQMSVCRMFI
CCCCCCCCCHHEEEE
3.3521406390
362PhosphorylationTLTTNQMSVCRMFIL
CCCCCCCCHHEEEEE
14.3226437602
376PhosphorylationLDRVEGDTCSLNEFT
EEECCCCCCCCEEEE
18.1725850435
378PhosphorylationRVEGDTCSLNEFTIT
ECCCCCCCCEEEEEE
36.0025849741
383PhosphorylationTCSLNEFTITGSTYA
CCCCEEEEEECCEEE
16.0825850435
385PhosphorylationSLNEFTITGSTYAPI
CCEEEEEECCEEECC
23.2525850435
400UbiquitinationGEVHKDDKPVNCHQY
CEECCCCCCCCCCCC
62.08-
427PhosphorylationCNDSALDYNEAKGVY
HCCCCCCHHHHCCHH
18.76-
431UbiquitinationALDYNEAKGVYEKVG
CCCHHHHCCHHHHHH
42.61-
433UbiquitinationDYNEAKGVYEKVGEA
CHHHHCCHHHHHHHH
5.7121890473
4362-HydroxyisobutyrylationEAKGVYEKVGEATET
HHCCHHHHHHHHHHH
37.54-
436UbiquitinationEAKGVYEKVGEATET
HHCCHHHHHHHHHHH
37.54-
441PhosphorylationYEKVGEATETALTCL
HHHHHHHHHHHHHHH
29.5729255136
443PhosphorylationKVGEATETALTCLVE
HHHHHHHHHHHHHHH
23.7029255136
446PhosphorylationEATETALTCLVEKMN
HHHHHHHHHHHHHHC
11.0020860994
447GlutathionylationATETALTCLVEKMNV
HHHHHHHHHHHHHCC
4.1022555962
451AcetylationALTCLVEKMNVFDTE
HHHHHHHHHCCCCHH
28.4426051181
451UbiquitinationALTCLVEKMNVFDTE
HHHHHHHHHCCCCHH
28.44-
460UbiquitinationNVFDTELKGLSKIER
CCCCHHHCCCHHHHH
52.1221890473
4602-HydroxyisobutyrylationNVFDTELKGLSKIER
CCCCHHHCCCHHHHH
52.12-
460AcetylationNVFDTELKGLSKIER
CCCCHHHCCCHHHHH
52.1225953088
460GlycationNVFDTELKGLSKIER
CCCCHHHCCCHHHHH
52.12-
460UbiquitinationNVFDTELKGLSKIER
CCCCHHHCCCHHHHH
52.1221890473
460 (in isoform 1)Ubiquitination-52.1221890473
460 (in isoform 2)Ubiquitination-52.1221890473
464AcetylationTELKGLSKIERANAC
HHHCCCHHHHHHHHH
54.3423749302
464MalonylationTELKGLSKIERANAC
HHHCCCHHHHHHHHH
54.3426320211
464UbiquitinationTELKGLSKIERANAC
HHHCCCHHHHHHHHH
54.3419608861
473PhosphorylationERANACNSVIKQLMK
HHHHHHHHHHHHHHC
25.7126437602
4762-HydroxyisobutyrylationNACNSVIKQLMKKEF
HHHHHHHHHHHCCCC
34.91-
476AcetylationNACNSVIKQLMKKEF
HHHHHHHHHHHCCCC
34.9125825284
476GlycationNACNSVIKQLMKKEF
HHHHHHHHHHHCCCC
34.91-
476UbiquitinationNACNSVIKQLMKKEF
HHHHHHHHHHHCCCC
34.91-
480SumoylationSVIKQLMKKEFTLEF
HHHHHHHCCCCEEEE
58.71-
480SumoylationSVIKQLMKKEFTLEF
HHHHHHHCCCCEEEE
58.71-
4812-HydroxyisobutyrylationVIKQLMKKEFTLEFS
HHHHHHCCCCEEEEE
44.06-
481AcetylationVIKQLMKKEFTLEFS
HHHHHHCCCCEEEEE
44.0654417127
481GlycationVIKQLMKKEFTLEFS
HHHHHHCCCCEEEEE
44.06-
481UbiquitinationVIKQLMKKEFTLEFS
HHHHHHCCCCEEEEE
44.06-
484PhosphorylationQLMKKEFTLEFSRDR
HHHCCCCEEEEECCC
26.8622673903
488PhosphorylationKEFTLEFSRDRKSMS
CCCEEEEECCCCCEE
24.7221712546
4922-HydroxyisobutyrylationLEFSRDRKSMSVYCT
EEEECCCCCEEEEEC
55.59-
492MalonylationLEFSRDRKSMSVYCT
EEEECCCCCEEEEEC
55.5926320211
492UbiquitinationLEFSRDRKSMSVYCT
EEEECCCCCEEEEEC
55.59-
493PhosphorylationEFSRDRKSMSVYCTP
EEECCCCCEEEEECC
19.7227080861
495PhosphorylationSRDRKSMSVYCTPNK
ECCCCCEEEEECCCC
19.6127080861
497NitrationDRKSMSVYCTPNKPS
CCCCEEEEECCCCCC
5.36-
497PhosphorylationDRKSMSVYCTPNKPS
CCCCEEEEECCCCCC
5.3629214152
498GlutathionylationRKSMSVYCTPNKPSR
CCCEEEEECCCCCCC
4.8322555962
498S-nitrosylationRKSMSVYCTPNKPSR
CCCEEEEECCCCCCC
4.8324105792
499PhosphorylationKSMSVYCTPNKPSRT
CCEEEEECCCCCCCC
16.5325159151
502AcetylationSVYCTPNKPSRTSMS
EEEECCCCCCCCCHH
45.6426051181
502UbiquitinationSVYCTPNKPSRTSMS
EEEECCCCCCCCCHH
45.64-
504PhosphorylationYCTPNKPSRTSMSKM
EECCCCCCCCCHHHH
50.2126437602
507PhosphorylationPNKPSRTSMSKMFVK
CCCCCCCCHHHHHCC
21.6826437602
510AcetylationPSRTSMSKMFVKGAP
CCCCCHHHHHCCCCC
27.9325953088
510MalonylationPSRTSMSKMFVKGAP
CCCCCHHHHHCCCCC
27.9326320211
510UbiquitinationPSRTSMSKMFVKGAP
CCCCCHHHHHCCCCC
27.93-
5142-HydroxyisobutyrylationSMSKMFVKGAPEGVI
CHHHHHCCCCCCCCC
37.78-
514AcetylationSMSKMFVKGAPEGVI
CHHHHHCCCCCCCCC
37.7826051181
514MalonylationSMSKMFVKGAPEGVI
CHHHHHCCCCCCCCC
37.7826320211
514UbiquitinationSMSKMFVKGAPEGVI
CHHHHHCCCCCCCCC
37.7821906983
514 (in isoform 1)Ubiquitination-37.7821890473
514 (in isoform 2)Ubiquitination-37.7821890473
523MethylationAPEGVIDRCTHIRVG
CCCCCCCCCCEEEEC
18.99115916469
524GlutathionylationPEGVIDRCTHIRVGS
CCCCCCCCCEEEECC
2.6215489859
525PhosphorylationEGVIDRCTHIRVGST
CCCCCCCCEEEECCC
22.6426437602
531PhosphorylationCTHIRVGSTKVPMTS
CCEEEECCCCCCCCH
23.3830108239
532PhosphorylationTHIRVGSTKVPMTSG
CEEEECCCCCCCCHH
30.0830108239
533UbiquitinationHIRVGSTKVPMTSGV
EEEECCCCCCCCHHH
46.1421906983
533 (in isoform 1)Ubiquitination-46.1421890473
533 (in isoform 2)Ubiquitination-46.1421890473
537PhosphorylationGSTKVPMTSGVKQKI
CCCCCCCCHHHHHHH
19.0926437602
538PhosphorylationSTKVPMTSGVKQKIM
CCCCCCCHHHHHHHH
35.0226437602
5412-HydroxyisobutyrylationVPMTSGVKQKIMSVI
CCCCHHHHHHHHHHH
49.77-
541AcetylationVPMTSGVKQKIMSVI
CCCCHHHHHHHHHHH
49.7725953088
541UbiquitinationVPMTSGVKQKIMSVI
CCCCHHHHHHHHHHH
49.7721906983
541 (in isoform 1)Ubiquitination-49.7721890473
541 (in isoform 2)Ubiquitination-49.7721890473
543UbiquitinationMTSGVKQKIMSVIRE
CCHHHHHHHHHHHHH
34.36-
546PhosphorylationGVKQKIMSVIREWGS
HHHHHHHHHHHHHCC
20.1929083192
549MethylationQKIMSVIREWGSGSD
HHHHHHHHHHCCCHH
31.31115916473
553PhosphorylationSVIREWGSGSDTLRC
HHHHHHCCCHHHHHH
35.8829083192
555PhosphorylationIREWGSGSDTLRCLA
HHHHCCCHHHHHHHH
29.1729083192
557PhosphorylationEWGSGSDTLRCLALA
HHCCCHHHHHHHHHH
20.1429083192
560S-nitrosocysteineSGSDTLRCLALATHD
CCHHHHHHHHHHCCC
2.68-
560GlutathionylationSGSDTLRCLALATHD
CCHHHHHHHHHHCCC
2.6815489859
560S-nitrosylationSGSDTLRCLALATHD
CCHHHHHHHHHHCCC
2.6820140087
575SulfoxidationNPLRREEMHLEDSAN
CCCHHHHCCHHHHCC
3.6121406390
580PhosphorylationEEMHLEDSANFIKYE
HHCCHHHHCCCEEEE
18.7526471730
585SumoylationEDSANFIKYETNLTF
HHHCCCEEEECCCEE
32.66-
585SumoylationEDSANFIKYETNLTF
HHHCCCEEEECCCEE
32.66-
586NitrationDSANFIKYETNLTFV
HHCCCEEEECCCEEE
24.14-
608PhosphorylationPPRIEVASSVKLCRQ
CCCCCHHHHHHHHHH
40.6229255136
609PhosphorylationPRIEVASSVKLCRQA
CCCCHHHHHHHHHHC
17.3429255136
611AcetylationIEVASSVKLCRQAGI
CCHHHHHHHHHHCCC
43.7626051181
611UbiquitinationIEVASSVKLCRQAGI
CCHHHHHHHHHHCCC
43.7622053931
611 (in isoform 1)Ubiquitination-43.7621890473
611 (in isoform 2)Ubiquitination-43.7621890473
613GlutathionylationVASSVKLCRQAGIRV
HHHHHHHHHHCCCEE
2.2215489859
623UbiquitinationAGIRVIMITGDNKGT
CCCEEEEEECCCCCH
2.4021890473
624PhosphorylationGIRVIMITGDNKGTA
CCEEEEEECCCCCHH
22.5421406692
628UbiquitinationIMITGDNKGTAVAIC
EEEECCCCCHHHHHH
63.48-
648PhosphorylationFGQDEDVTSKAFTGR
CCCCCCCCCCCCCCC
36.5122673903
649PhosphorylationGQDEDVTSKAFTGRE
CCCCCCCCCCCCCCC
23.1022673903
650UbiquitinationQDEDVTSKAFTGREF
CCCCCCCCCCCCCCH
37.8521890473
650AcetylationQDEDVTSKAFTGREF
CCCCCCCCCCCCCCH
37.8525953088
650UbiquitinationQDEDVTSKAFTGREF
CCCCCCCCCCCCCCH
37.8521890473
650 (in isoform 1)Ubiquitination-37.8521890473
650 (in isoform 2)Ubiquitination-37.8521890473
653PhosphorylationDVTSKAFTGREFDEL
CCCCCCCCCCCHHHC
39.9423403867
663PhosphorylationEFDELNPSAQRDACL
CHHHCCHHHHHHHHH
35.6419664994
669GlutathionylationPSAQRDACLNARCFA
HHHHHHHHHHHHHHE
3.3615489859
674GlutathionylationDACLNARCFARVEPS
HHHHHHHHHEECCCC
2.6522833525
683GlycationARVEPSHKSKIVEFL
EECCCCCHHHHHHHH
58.75-
683UbiquitinationARVEPSHKSKIVEFL
EECCCCCHHHHHHHH
58.75-
685UbiquitinationVEPSHKSKIVEFLQS
CCCCCHHHHHHHHHC
56.42-
685 (in isoform 2)Ubiquitination-56.42-
692PhosphorylationKIVEFLQSFDEITAM
HHHHHHHCCHHHHCC
36.4922673903
697PhosphorylationLQSFDEITAMTGDGV
HHCCHHHHCCCCCCC
14.3422673903
699SulfoxidationSFDEITAMTGDGVND
CCHHHHCCCCCCCCC
3.0128183972
711UbiquitinationVNDAPALKKAEIGIA
CCCCHHHHHCCCEEE
52.6321906983
711 (in isoform 1)Ubiquitination-52.6321890473
711 (in isoform 2)Ubiquitination-52.6321890473
712UbiquitinationNDAPALKKAEIGIAM
CCCHHHHHCCCEEEE
52.69-
712 (in isoform 1)Ubiquitination-52.6921890473
712 (in isoform 2)Ubiquitination-52.6921890473
721PhosphorylationEIGIAMGSGTAVAKT
CCEEEECCCHHHHHC
21.64-
723PhosphorylationGIAMGSGTAVAKTAS
EEEECCCHHHHHCHH
21.4730278072
728PhosphorylationSGTAVAKTASEMVLA
CCHHHHHCHHHHHCC
26.1930278072
730UbiquitinationTAVAKTASEMVLADD
HHHHHCHHHHHCCCC
31.3021890473
730PhosphorylationTAVAKTASEMVLADD
HHHHHCHHHHHCCCC
31.3030278072
732SulfoxidationVAKTASEMVLADDNF
HHHCHHHHHCCCCCC
2.5128183972
740PhosphorylationVLADDNFSTIVAAVE
HCCCCCCHHHHHHHH
24.3924719451
741PhosphorylationLADDNFSTIVAAVEE
CCCCCCHHHHHHHHH
18.48-
753NitrationVEEGRAIYNNMKQFI
HHHHHHHHHCHHHHH
10.25-
757UbiquitinationRAIYNNMKQFIRYLI
HHHHHCHHHHHHHHH
44.1521890473
7572-HydroxyisobutyrylationRAIYNNMKQFIRYLI
HHHHHCHHHHHHHHH
44.15-
757AcetylationRAIYNNMKQFIRYLI
HHHHHCHHHHHHHHH
44.1524588123
757UbiquitinationRAIYNNMKQFIRYLI
HHHHHCHHHHHHHHH
44.1521890473
757 (in isoform 1)Ubiquitination-44.1521890473
757 (in isoform 2)Ubiquitination-44.1521890473
824UbiquitinationNKPPRNPKEPLISGW
CCCCCCCCCCCHHHH
75.43-
829PhosphorylationNPKEPLISGWLFFRY
CCCCCCHHHHHHHHH
31.4427251275
836PhosphorylationSGWLFFRYLAIGCYV
HHHHHHHHHHHHHHH
8.70-
867PhosphorylationGGPRVSFYQLSHFLQ
CCCEEEEEHHHHHHC
10.88-
920PhosphorylationNSLSENQSLLRMPPW
HCCCCCCCHHCCCCC
40.7424719451
973PhosphorylationWLMVLKISLPVILMD
HHHHHHHCCCCHHCC
25.65-
982PhosphorylationPVILMDETLKFVARN
CCHHCCHHHHHHHHH
30.86-
990NitrationLKFVARNYLEPGKEC
HHHHHHHCCCCCCCC
13.59-
990PhosphorylationLKFVARNYLEPGKEC
HHHHHHHCCCCCCCC
13.5928152594
995AcetylationRNYLEPGKECVQPAT
HHCCCCCCCCCCCCC
59.6726051181
995MalonylationRNYLEPGKECVQPAT
HHCCCCCCCCCCCCC
59.6726320211
995UbiquitinationRNYLEPGKECVQPAT
HHCCCCCCCCCCCCC
59.672190698
995 (in isoform 1)Ubiquitination-59.6721890473
997GlutathionylationYLEPGKECVQPATKS
CCCCCCCCCCCCCCC
3.8222555962

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
38SPhosphorylationKinaseCAMK2-FAMILY-GPS
38SPhosphorylationKinaseCAMK-FAMILY-GPS
38SPhosphorylationKinaseCAM-KII_GROUP-PhosphoELM

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of AT2A2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of AT2A2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
PPLA_HUMANPLNphysical
11854448
ITPR3_HUMANITPR3physical
22939629
NDUS4_HUMANNDUFS4physical
26344197
NOTC2_HUMANNOTCH2physical
26344197

Drug and Disease Associations
Kegg Disease
H00715 Darier disease; Dyskeratosis follicularis
H00755 Acrokeratosis verruciformis
OMIM Disease
101900Acrokeratosis verruciformis (AKV)
124200Darier disease (DD)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of AT2A2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-464, AND MASS SPECTROMETRY.
Nitration
ReferencePubMed
"Detection of sequence-specific tyrosine nitration of manganese SODand SERCA in cardiovascular disease and aging.";
Xu S., Ying J., Jiang B., Guo W., Adachi T., Sharov V., Lazar H.,Menzoian J., Knyushko T.V., Bigelow D., Schoeneich C., Cohen R.A.;
Am. J. Physiol. 290:H2220-H2227(2006).
Cited for: NITRATION AT TYR-294 AND TYR-295.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-663, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-663, AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-663, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-663, AND MASSSPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-663, AND MASSSPECTROMETRY.

TOP